Warszawski Szpital Okulistyczny Sp. z o.o.

Warsaw 15 trials 6 recruiting

15 Registered trials

6 Currently recruiting

Organisation

Warszawski Szpital Okulistyczny Sp. z o.o.

Location

Warsaw, Poland

Identifier

ORG-100044696

Address

Ul. Wolska 165/u7, 01-258, Poland

Departments

2212; Warszawski Szpital Okulistyczny
2212: Warszawski Szpital Okulistyczny
2212:Warszawski Szpital Okulistyczny
n/a
NA
Ophtalmology
Ophthalmology
POL5: Opthalmology
Warszawski Szpital Okulistyczny

Clinical trials at this site (15)

Search interface

A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8… Recruiting

2025-524575-22-00 Neovascular age-related macular degeneration (NVAMD) 10 2026-06-30
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Active Thyroid Eye Disease (TED) Recruiting

2024-514972-42-00 Thyroid eye disease 5 2025-02-25
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME Recruiting

2025-523937-25-00 Diabetic Macular Edema (DME) 5 2026-05-06
A study to test whether BI 1815368 helps people with an eye condition called diabetic macular edema Recruiting

2024-520384-14-00 Centre-involved diabetic macular edema 4 2025-11-20
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Geographic Atrophy 4 2025-02-27
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER). Recruiting

2023-504751-28-00 Exudative age-related macular degeneration 5 2024-09-24
A Safety, and Tolerability Study of VRDN-003 in Participants with Thyroid Eye Disease (TED) Ended

2024-519417-57-00 Thyroid eye disease 5 2025-06-25
LUCIA: A Phase 3 randomized, double-masked study comparing the efficacy of EYP-1901 against aflibercept Ended

2024-518030-83-00 Wet age-related macular degeneration (wAMD) 5 2025-06-05
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
A Phase 3 Study of Brepocitinib in Adults with Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) Ended

2024-515089-15-00 active non-infectious uveitis (intermediate uveitis, po 5 2025-02-28
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants with Chronic Thyroid Eye Disease (TED) Ended

2024-514973-23-00 Thyroid eye disease 5 2025-02-25
A study to test whether BI 764524 helps people with an eye condition called diabetic retinopathy Ended

2023-508891-12-00 Diabetic retinopathy 4 2024-11-28
A phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine… Ended

2024-516315-24-00 myopia 5 2022-05-27
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Geographic Atrophy 4 2023-08-11
A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio… Ended

2023-509206-29-00 Neovascular age-related macular degeneration (nAMD) 5